Send your comments and tips to whitecoat@globe.com
  Awards Beth Israel Deaconess Medical Ctr. Boston Medical Center Boston University Brigham and Women's Hospital Broad Institute Cambridge Health Alliance Caritas St. Elizabeth's Medical Ctr. Children's Hospital Boston Dana-Farber Cancer Institute Grants Harvard University Joslin Diabetes Center Lahey Clinic Mass. General Hospital Mass. Health Law McLean Hospital MIT New England Baptist Hospital Personnel Moves Public Health Research Short White Coat Tufts-New England Medical Center Tufts University UMass Memorial Medical Center University of Massachusetts VA Medical Centers    A Healthy Blog Running A Hospital Nature Network Boston SciBos - Corie Lok's blog Kevin, M.D. Blog, MD Nurse at small Dr. Gwenn Is In Healthy Children blog WBUR's CommonHealth Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram &
Gazette.
Boston Globe Health and Science staff:
Scott Allen Alice Dembner Carey Goldberg Liz Kowalczyk Stephen Smith Colin Nickerson Beth Daley Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor. Short White Coat blogger Ishani Ganguli Short White Coat blogger Jennifer Srygley  Week of:
November 11
Week of:
November 4
Week of:
October 28
Week of:
October 21
Week of:
October 14
Week of:
October 7
|
« 'Prostatempathy' may guide inappropriate PSA test ordering, study says | Main | New hope for stroke patients in latest robotics » Tuesday, July 10, 2007Today's Globe: antismoking ads, nursing program, RNAi deal
Graphic television ads starring former smoker and cancer survivor Ronaldo Martinez (above), his tinny, robotic voice warning of the consequences of cigarettes, used to run in Massachusetts until 2001 budget cuts. The Massachusetts Legislature voted last week to reinvigorate the tobacco-control program, boosting its budget to $12.75 million for next year, from $8.25 million this year. State regulatory officials have taken the unusual step of barring Massachusetts Bay Community College from accepting new applicants in its popular nursing school. In the latest endorsement of a science technique discovered at the University of Massachusetts, the international drug giant Roche signed a $331 million deal with Alnylam Pharmaceuticals Inc. of Cambridge for the rights to develop drugs using RNA interference. Posted by Elizabeth Cooney at 06:56 AM
|
